|
Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial. |
| |
|
Stock and Other Ownership Interests - InBiomotion |
Honoraria - AstraZeneca/Daiichi Sankyo; Lilly; MSD; Pfizer; Sysmex |
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Pfizer; Seagen |
Research Funding - AstraZeneca/Daiichi Sankyo; Biobots; Roche |
Patents, Royalties, Other Intellectual Property - Biocartis |
Travel, Accommodations, Expenses - MSD; Novartis |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Biovica |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Incyte; MSD Oncology; Roche (Inst) |
Research Funding - Celgene (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Roche |
| |
|
Consulting or Advisory Role - AstraZeneca; Lilly; MSD; Novartis; Pfizer; Pierre Fabre |
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD |
| |
|
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche |
Research Funding - Pfizer |
Travel, Accommodations, Expenses - Pfizer |
| |
|
Consulting or Advisory Role - AstraZeneca; AstraZeneca/Daiichi Sankyo; MSD; Novartis; Pfizer; Pierre Fabre; Seagen |
Speakers' Bureau - Novartis; Pfizer |
Research Funding - Pfizer (Inst) |
Travel, Accommodations, Expenses - Novartis; Pfizer; Pfizer |
| |
|
Consulting or Advisory Role - Seagen |
Travel, Accommodations, Expenses - GlaxoSmithKline/MSD |
| |
|
Speakers' Bureau - AstraZeneca; GlaxoSmithKline |
Travel, Accommodations, Expenses - GlaxoSmithKline |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Novartis; pfizer; Roche/Genentech |
Consulting or Advisory Role - Puma Biotechnology; Roche |
| |
|
Honoraria - AstraZeneca; Genomic Health; Gilead Sciences; Novartis; Novartis; Pfizer; Roche; Seagen |
Consulting or Advisory Role - Novartis |
Research Funding - Genomic Health (Inst); Teva |
Travel, Accommodations, Expenses - Roche/Genentech |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca; Biovica |
| |
Federico Gustavo Rojo Todo |
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; GlaxoSmithKline; Lilly; Menarini; Merck; MSD; Novartis; Roche |
Research Funding - AstraZeneca; Menarini |